Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.

Marcellin P, Ahn SH, Chuang WL, Hui AJ, Tabak F, Mehta R, Petersen J, Lee CM, Ma X, Caruntu FA, Tak WY, Elkhashab M, Lin L, Wu G, Martins EB, Charuworn P, Yee LJ, Lim SG, Foster GR, Fung S, Morano L, Samuel D, Agarwal K, Idilman R, Strasser SI, Buti M, Gaeta GB, Papatheodoridis G, Flisiak R, Chan HL

Open source

DOI: 10.1111/apt.13779
Published: 2016 Nov
Container: Alimentary pharmacology & therapeutics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/apt.13779,
  title = {Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.},
  author = {Marcellin P and Ahn SH and Chuang WL and Hui AJ and Tabak F and Mehta R and Petersen J and Lee CM and Ma X and Caruntu FA and Tak WY and Elkhashab M and Lin L and Wu G and Martins EB and Charuworn P and Yee LJ and Lim SG and Foster GR and Fung S and Morano L and Samuel D and Agarwal K and Idilman R and Strasser SI and Buti M and Gaeta GB and Papatheodoridis G and Flisiak R and Chan HL},
  year = {2016},
  journal = {Alimentary pharmacology \& therapeutics},
  doi = {10.1111/apt.13779},
  url = {https://doi.org/10.1111/apt.13779}
}

RIS

TY  - JOUR
TI  - Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.
AU  - Marcellin P
AU  - Ahn SH
AU  - Chuang WL
AU  - Hui AJ
AU  - Tabak F
AU  - Mehta R
AU  - Petersen J
AU  - Lee CM
AU  - Ma X
AU  - Caruntu FA
AU  - Tak WY
AU  - Elkhashab M
AU  - Lin L
AU  - Wu G
AU  - Martins EB
AU  - Charuworn P
AU  - Yee LJ
AU  - Lim SG
AU  - Foster GR
AU  - Fung S
AU  - Morano L
AU  - Samuel D
AU  - Agarwal K
AU  - Idilman R
AU  - Strasser SI
AU  - Buti M
AU  - Gaeta GB
AU  - Papatheodoridis G
AU  - Flisiak R
AU  - Chan HL
PY  - 2016
JO  - Alimentary pharmacology & therapeutics
DO  - 10.1111/apt.13779
UR  - https://doi.org/10.1111/apt.13779
ER  -

APA

P, M., SH, A., WL, C., AJ, H., F, T., R, M., J, P., CM, L., X, M., FA, C., WY, T., M, E., L, L., G, W., EB, M., P, C., LJ, Y., SG, L., GR, F., S, F., L, M., D, S., K, A., R, I., SI, S., M, B., GB, G., G, P., R, F., & HL, C. (2016). Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.. Alimentary pharmacology & therapeutics. https://doi.org/10.1111/apt.13779

Source records

pubmed · retrieved 2026-11-10T04:59:09.102Z